公司资料
Forte Biosciences 股价、新闻与催化剂
- 股票代码:
- FBRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
76.95 USD (+0.04%)
收盘价
最后更新: 2026年8月24日
372M USD
市值
股价为何变动
As of Aug 24, 2026, FBRX was little changed and closed at $76.95. No new same-company headline was identified in the current news window.
公司概览
业务概览
Forte Biosciences is a clinical-stage biotechnology company focused on dermatology and immune-mediated disease. Its profile is built around translating immune and skin biology into differentiated therapies.
所在地与行业分类
Forte is headquartered in the United States and listed on NASDAQ. It sits in specialty biotech with a dermatology and immunology focus.
商业模式特征
The company depends on clinical progress, dose selection, and pipeline prioritization to create value. Investors usually watch proof-of-concept data and whether the company can build a differentiated immune-dermatology franchise.
生物医药行业定位
Forte occupies a small but catalyst-sensitive dermatology niche within biotech. The stock is typically driven by clinical updates and the market's view of the platform's differentiation.
未来催化剂
- Forte Biosciences’ catalysts are FB-102 and any dermatology / immune-disease update that shows the program still has a strong path. The market will care about whether the next data point supports the platform thesis.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。